Antibiotics 2026—Advances in Antimicrobial Action and Resistance
Antibiotics 2026—Advances in Antimicrobial Action and Resistance
13 January 2026
10 February 2026
15 March 2026
29 March 2026
4 May 2026
resistance, antibiotics, antimicrobials, one health, ethnopharmacology, stewardship, antimicrobial discovery, antimicrobial therapy, antimicrobial research
Welcome from the Chairs
Dear Colleagues,
We are pleased to welcome you to Antibiotics 2026—Advances in Antimicrobial Action and Resistance, which will take place in Barcelona, Spain, from the 11th to the 14th of May 2026. This conference aims to bring together researchers, industry professionals, and experts from around the world to share the latest advancements, exchange ideas, and foster collaboration in the field of antimicrobials, antimicrobial resistance, and innovative therapeutic strategies.
Over the course of four days, we will explore a wide range of topics, including antimicrobial resistance mechanisms, antimicrobials and One Health, ethnopharmacology in antimicrobial research and treatment, conventional and novel approaches in the discovery of new antimicrobial agents, and innovation in antimicrobial stewardship and optimized clinical strategies, through keynote lectures, oral presentations, and poster sessions. Our program is designed to provide an engaging platform for discussing cutting-edge research, emerging challenges, and future directions in the field.
We encourage you to actively participate by presenting your work, engaging in discussions, and networking with fellow attendees. Beyond the scientific sessions, Barcelona offers a vibrant setting to connect with colleagues while enjoying its rich culture, history, and cuisine.
We look forward to an inspiring and productive conference and to welcoming you to Antibiotics 2026.
Sincerely,
Prof. Dr. Manuel Simões
Prof. Dr. Jordi Vila
Prof. Dr. Nicholas Dixon
Dr. Marc Maresca
Conference Secretariat
Ms. Raquel Sellés
Ms. Roberta Miglioranza
Dr. Elena Gonzalez
antibiotics2026@mdpi.com
Join us on LinkedIn Events!
If you want to stay updated with the latest information, or if you want to connect with your fellow researchers before, during, and after the event, then be sure to join the Antibiotics 2026 – Advances in Antimicrobial Action and Resistance LinkedIn Event.
See you over there!
Follow the conversation on X with #Antibiotics2026
Event Chairs
Department of Chemical Engineering, Faculty of Engineering, University of Porto, Portugal
Prof. Dr. Manuel Simões is an Associate Professor with Habilitation in the Department of Chemical Engineering at the University of Porto (FEUP). He holds a PhD in Chemical and Biological Engineering from the University of Minho, Portugal. Since 2020, he has been recognized as a Clarivate Highly Cited Researcher, having published over 200 peer-reviewed articles, 5 books, and more than 40 book chapters in international publications. His work is centred around understanding the mechanisms of biofilm formation and developing innovative, sustainable approaches to control microbial communities using advanced bioprocess engineering. His areas of interest include biofilm science and technology, antimicrobial resistance, disinfection, emerging antimicrobial strategies, and the use of microalgae in bioremediation.
Prof. Dr. Jordi Vila is a Research Professor at the Barcelona Institute for Global Health (ISGlobal), the Head of the Clinical Microbiology Department of the Hospital Clínic of Barcelona, and a Professor at the School of Medicine of the University of Barcelona (UB). In addition, he leads the Antibiotic Resistance Initiative at the Barcelona Institute for Global Health (ISGlobal). His main field of research is the development of new antibiotics against multi-resistant bacteria and molecular tools for the rapid diagnosis of infectious diseases. Prof. Dr. Vila was the Director of the Congress of the European Society for Clinical Microbiology and Infectious Diseases (ESCMID) from 2009 to 2014 and a member of the ICAAC Scientific Committee for 4 years. He is currently the President of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC). He has published 450 articles in peer-reviewed journals and has two patented molecules. His lines of research include the design of new antibiotics against multidrug-resistant bacteria, research on the molecular bases of antimicrobial resistance, and the development of new rapid diagnostic tools to diagnose infectious diseases.
Molecular Horizons and School of Chemistry and Molecular Bioscience, University of Wollongong, Australia
Prof. Dr. Nicholas Dixon holds a PhD in Biochemistry from the University of Queensland (1978). He was a Research Fellow with Prof Alan Sargeson (Research School of Chemistry, ANU) before being awarded the C.J. Martin and Fulbright Fellowships to study with Nobel laureate Prof. Arthur Kornberg at Stanford University, U.S.A. He returned to the John Curtin School of Medical Research at ANU as a Queen Elizabeth II Fellow in 1983, and was appointed as Fellow in Biological Chemistry at the Research School of Chemistry, ANU, in 1986. He was subsequently promoted to Senior Fellow and Professor, before leaving ANU in 2006 to take up his present position as Professor of Biological Chemistry at the University of Wollongong. He was awarded an Australian Research Council Australian Professorial Fellowship in 2008 and established the UOWs Centre for Medical and Molecular Bioscience in 2010. He is currently an academic leader of Molecular Horizons, a new facility for molecular visualization which opened in 2019. His research focuses on biochemistry and cell biology, medicinal and biomolecular chemistry, enzymes, and structural biology, including macromolecular modelling.
Dr. Marc Maresca is a researcher at the Institut des Sciences Moléculaires de Marseille (ISM2, UMR 7313) at Aix-Marseille University, France, where he has been working since 2011. With a strong interdisciplinary background in chemistry and biology and a PhD from Université Paul Cézanne (IMRN) in Aix-en-Provence, France, his work focuses on the development and application of antimicrobial molecules—particularly antimicrobial peptides—for use in human and animal health. In parallel, Dr. Maresca also conducts research in food safety, with a specific focus on mycotoxins and their impact on human health. Beyond academic research, he serves as a scientific expert and consultant for private pharmaceutical companies.
Keynote Speakers
Element Materials Technology, JMI Laboratories, USA
Mariana Castanheira, Ph.D., has a science degree in Pharmacy and Biochemistry. She completed her Master of Science and Doctoral (Ph.D.) degrees for evaluating molecular epidemiology and resistance mechanisms of Gram-positive and -negative bacteria at Universidade Federal de Sao Paulo (UNIFESP). Dr. Castanheira also received training in the Department of Pathology and Microbiology of the University of Bristol (United Kingdom) to study beta-lactamases. She built on the knowledge gained at Bristol by dedicating the past 20 years to working on discovering and characterizing genes encoding beta-lactamases and other resistance mechanisms. Dr. Castanheira has served as the chief scientific officer at JMI Laboratories since January 2020. Previously, she spent 2 years serving as JMI’s chief operations officer, during which time she oversaw all service divisions and identified opportunities to improve the organization. Now, she is broadening and promoting the scientific endeavours of JMI Laboratories. She is further responsible for designing and overseeing antimicrobial and antifungal drug development projects, surveillance studies and molecular projects that characterize resistance mechanisms. Dr. Castanheira is the leading author of over 250 peer-reviewed publications, presents annually at major field conferences, and interfaces with a global network of research collaborators. Dr. Castanheira was an associate editor for Diagnostic Microbiology and Infectious Diseases (2008-2014) and is currently an editor for mSphere (since 2015). She is also a member of the editorial board for Antimicrobial Agents and Chemotherapy, the Journal of Clinical Microbiology, Microbial Drug Resistance, and Drug Resistance Updates. She also serves as an ad hoc reviewer for many other microbiology journals.
Invited Speakers
Dr. Jean-Michel Bolla is the current Director of Research at INSERM and UMR-MD1, Faculty of Pharmacy, Aix-Marseille University, France. After receiving his Masters in Biochemistry and Molecular Biology from the University of Nice in 1985 and his doctorate in Microbiology and Molecular Biology at Aix-Marseille University in 1991, he obtained a post-doctorate degree in Medical and Bacterial Microbiology from the Necker Faculty of Medicine and the Enfants Malades Hospital in Paris in 1992. In 2001, he returned to Aix-Marseille University to receive his habilitation. His research focuses on bacterial microbiology, physiology and biochemistry, antibiotic resistance via efflux pumps, and the design and evaluation of new antibiotics and new antibiotic adjuvants. He is the author and co-author of 70 peer-reviewed publications, owns 4 patents, and has actively participated in 18 conferences, including 3 Gordon Research Conferences (2011, 2013, and 2015). Between 2007 and 2011, he was an honorary professor, after winning an Inserm-University of Corsica "Interface Contract" (2007-2011). Throughout his career, he has secured multiple grants, including three ANR grants and partnerships with DGA-DGCIS, SATT (PI) Amidex Foundation, and FEAPM (partner). Between 2013 and 2018, he was a member of the European Program Innovative Medicines Initiative (IMI) “New Drugs for Bad Bugs”, in Jean Marie Pagès’ team. He was also active in the translocation project "Molecular basis of the bacterial cell wall permeability".
Prof. Dr. Efstathios (Stathis) Giaouris is Associate Professor of Food Microbiology at the Department of Food Science and Nutrition, University of the Aegean. He holds an MSc in Food Science and Technology (2003) and a PhD in Agricultural Sciences (with a focus on food microbiology) (2008) from the Agricultural University of Athens. A significant part of his doctoral research was conducted at INRA–AgroParisTech in Paris, supported by a European Union Marie Curie Fellowship. He has participated in numerous funded projects on food microbiology, hygiene, and safety, collaborating with academic institutions, research centers, and the food industry. His research output includes over 60 peer-reviewed articles (with more than 2,800 citations; h-index 28, Scopus), nine book chapters, and over 100 presentations at conferences and workshops (including 28 oral presentations at international events, several of which he was invited to deliver). Prof. Giaouris serves on the editorial boards of multiple international scientific journals, including Food Microbiology, Journal of Food Protection, Foods, and Heliyon, and has reviewed over 450 manuscripts and research proposals for national and international bodies. He is also a member of several scientific societies, including the Food Safety Working Group of the Greek Technology Platform “Food for Life”. Registered as a trainer with the Hellenic Food Authority (EFET), he provides specialized training in food hygiene and safety to professionals and food control agencies.
Prof. Dr. Evelina Tacconelli (MD, PhD) is a Professor of Infectious Diseases at the University of Verona, Italy, the Director of the Infectious Diseases Section at the Verona University Hospital, Italy, and a consultant on infectious diseases research for the University of Tübingen, Germany. In her career, she has been a Lecturer of Medicine at the Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, USA, as well as a consultant for WHO, ECDC, and EMA on infection control and antimicrobial resistance. She has a long history in the participation and coordination of European projects and networks focused on antimicrobial resistance, including ORCHESTRA (GA n° 101016167), a research project funded by the Horizon 2020 Program to better inform COVID-19 prevention and treatment and improve preparedness for future pandemics. In her role as ESCMID Guideline Officer for Infectious Diseases and Clinical Microbiology and Chair of the European Committee of Infection Control (EUCIC), she was the chief author of the ESCMID guidelines for the management and control of infections due to MDR-Gram negatives and the EUCIC guidelines for the decolonization of MDR-gram negatives. She is also the coordinator of the Italian working group on optimizing antibiotic prescriptions for AIFA, the Italian Medicine Agency. Her main areas of scientific interest are epidemiology, the clinical and therapeutic aspects of healthcare-associated infections, and preventive measures aimed at reducing the spread of antibiotic-resistant bacteria.
Bijvoet Centre for Biomolecular Research, Chemistry Department, Utrecht University, The Netherlands
Markus Weingarth studied Biochemistry in Greifswald (Germany), followed by a PhD in NMR methodology from École Normale Supérieure in Paris (France). At Utrecht University (the Netherlands), his research group focuses on the molecular mechanisms by which antibiotics target bacterial cell envelopes. Using integrative structural biology approaches, his team has uncovered novel supramolecular killing mechanisms and pioneered solid-state NMR techniques that enable high-resolution studies of antibiotic action directly in intact bacteria. For his antibiotics research, Weingarth has received several honors, including an ERC Consolidator grant (2022, 2M€) and the ‘Founders’ Medal’ (2022) of the ‘International Council on Magnetic Resonance in Biological Systems’, the leading award for mid-career researchers in the NMR field. In 2025, he secured major funding ((VICI, 1.5M€; KIC, 1.5M€) from the Dutch Research Council to develop concepts and technologies for studying how antibiotics target Gram-negatives and Mycobacteria. More information about his research can be found at www.weingarth-group.org.
Sessions
S2. Antimicrobials, Antimicrobial Resistance, and One Health
S3. Ethnopharmacology in Antimicrobial Research and Treatment
S4. Conventional and Novel Approaches in the Discovery of New Antimicrobial Agents
S5. Innovation in Antimicrobial Stewardship and Optimized Clinical Strategies
Registration
In-Person Registration
The conference will be held fully in person; it is not possible to participate online. The registration fee includes attendance at all conference sessions, morning/afternoon coffee breaks, lunches, a conference bag, and a program book. Participation in the conference is considered final only once the registration fees have been paid. The number of participants is limited: once the number of paid registrations reaches the maximum number of participants, unpaid registrations will be canceled.
When registering, please provide us with your institutional email address. This will accelerate the registration process.
Important Information
Please note that abstract submission and conference registration are two separate processes. During registration, please provide us with the same email address you used to submit your abstract(s). Otherwise, leave us a comment in the registration form, providing the email address used during the submission process. In addition, please use your institutional email address for both processes.
In order to finalize the scientific program in due time, at least one registration by any of the authors, denoted as the Covering Author, is required to cover the presentation and publication of any accepted abstract. The Covering Author registration deadline is 29 March 2026. Your abstract will be withdrawn if your registration is not complete by this date.
Group Registration: Groups of five or more attendees are offered a 10% discount on the registration fees. To enjoy this discount, you need to complete one multiple registration by selecting the number of people attending in each category (type of registration) during the first step of the registration process. Please note that no other discounts will be applicable.
Certificate of Attendance: Participants of the event will be able to download an electronic Certificate of Attendance by accessing their dashboards on Sciforum.net once the event is concluded. The certificates will be found under the "My Certificates" category.
Reduced fees
If you are affiliated with a university in a low- or middle-income country, you are automatically eligible for a price reduction. However, please note that the reduced price will only be added to your registration when it is processed. This means that you do not have to pay the stated price immediately upon registration, and you will receive an invoice with the price adjustment after you have registered. Below, you can find the list of low- and middle-income countries.
Registration Fees
|
Early Bird Until 15 March 2026 |
Regular Until 4 May 2026 |
Supported documents | |
|---|---|---|---|
| Academic | 590.00 EUR | 690.00 EUR | |
| Student | 290.00 EUR | 390.00 EUR |
Scanned copy or photograph of your current student ID is required. |
| EBM/GE | 490.00 EUR | 590.00 EUR | |
| Author/Reviewer | 550.00 EUR | 650.00 EUR | |
| Non-Academic | 890.00 EUR | 990.00 EUR |
| Chairs, Invited Speakers, MDPI Guests |
Active discounts
Group of 5: 10% discount
Note: Group size refers to the number of registered attendees in the same registration order.
Cancellation policy
| Cancellation of paid registration is possible under the terms listed below: | |
| > 2 months before the conference | Full refund but 60 EUR is retained for administration |
| > 1 month before the conference | Refund 50% of the applying fees |
| > 2 weeks before the conference | Refund 25% of the applying fees |
| < 2 weeks before the conference | No refund |
Disclaimer
In the unlikely event that MDPI deems it necessary to cancel the conference, all pre-paid registration fees will be reimbursed. MDPI shall not be liable for reimbursing the cost of travel or accommodation arrangements made by individual delegates.
Beware of unauthorized registration and hotel solicitations
Note that Sciforum is the only official registration platform to register to Antibiotics 2026 and that we are not associated with any hotel agency. While other hotel resellers and travel agencies may contact you with offers for your trip, they are not endorsed by or affiliated with Antibiotics 2026 or Sciforum. Beware that entering into financial agreements with non-endorsed companies can have costly consequences.
Insurance
The organizers do not accept liability for personal accident, loss, or damage to private property incurred as a result of participation in Antibiotics 2026. Delegates are advised to arrange appropriate insurance to cover travel, cancellation, or medical costs, and theft or damage of belongings.
MDPI Conference Admissions Policy
-
All registered conference delegates are asked to always wear their badges throughout the conference.
-
Conference sessions, the catering area, and the poster area are solely restricted to badge holders. Any person attending these areas without a badge will be asked to leave the premises.
-
Badge holders must not allow their badges to be worn by anyone else. Any failure to do so is likely to lead to the badge holder and the person wearing the badge being removed from the premises.
-
Press badges are restricted to publishers, editors, journalists, broadcasters, and web bloggers associated with the conference subject area. Members of the press may be asked to produce accreditation in the form of a photocopy of a recognized press or media card, a business card, a letter from the editor, or an official web address linking to a press release in order to verify their position.
-
Photographs and videos may be taken during the conference. Anyone attending the conference consents to such photography and filming without compensation and confirms that the organizers shall be entitled to use such photographs and videos, which may include photographs and videos of visitors, for the purpose of marketing the conference in the future and for exploitation in any and all media, without liability.
Payment methods
Wire transfer, Credit card
Currencies accepted by this event
Swiss francs (CHF) , Euros (EUR) , US dollars (USD) , Pounds sterling (GBP) , Japanese yen (JPY) , Canadian dollars (CAD) and Singapore dollars (SGD)
Instructions for Authors
Antibiotics 2026 will accept abstracts only. The accepted abstracts will be available online on Sciforum.net during and after the conference. Moreover, participants will have the opportunity to contribute with a full manuscript to a Special Issue related to the conference in the open-access journal Antibiotics, with a 20% discount on the publication fees.
The conference will be held fully in person; it is not possible to participate online.
Please note that abstract submission and conference registration are two separate processes. Please use your institutional email address for both processes.
To present your research at the event
- Create an account on Sciforum if you do not have one and then click on ‘New Submission’ in the upper-right corner of the window; or, click on ‘Submit Abstract’ at the top of this webpage.
- Choose a session that is best suited for your research.
- Submit an abstract in English—the word limits are a minimum of 150 words and a maximum of 300 words.
- The deadline to submit your abstract is 13 January 2026.
- Upon submission, you can select if you wish to be considered for oral or poster presentation (or both). Following assessment by the Chairs and Scientific Committee, you will be notified by 10 February 2026 whether your contribution has been accepted for oral or poster presentation.
- Please note that, in order to finalize the scientific program in due time, at least one registration by any of the authors, denoted as the Covering Author, is required to cover the presentation and publication of any accepted abstract. The Covering Author registration deadline is 29 March 2026. Your abstract will be withdrawn if your registration is not complete by this date.
Oral Presentations
Invited talks will be 30 minutes long, including questions (25-minute oral presentation + 5-minute Q&A). Short talks will be 15 minutes long, including questions (10-minute oral presentation + 5-minute Q&A). Please ensure that your slides are formatted in a widescreen (16:9) aspect ratio.
Poster Presentations
Each presenter will be provided with a vertical poster board. Maximum poster size is limited to A0: 84 x 120 cm / 33 x 47 in (width x height) in the vertical orientation (portrait). Please print your poster prior to the conference. A plan for the poster session will be circulated later. For suggestions on poster design, click the button below.
Event Awards
To recognize the outstanding works presented during our conference, we are excited to announce two awards for our participants. Sponsored by the journal Antibiotics, we will offer one Best Oral Presentation Award and one Best Poster Award.
The Awards
Number of Awards Available: 1
Prize: EUR 500
Number of Awards Available: 1
Prize: EUR 500
Location and Venue
UPF - BSM
Address: C/ de Balmes, 132, 134, 08008 Barcelona, Spain
Plan Your Trip
Barcelona
Barcelona is the capital of Catalonia and Spain's second-largest city, with a population of over one and a half million people.
Located on the northeastern Mediterranean coast of Spain, this city has a rich and diverse history, with its roots dating back to Roman times. The fruitful medieval period established Barcelona's position as the economic and political center of the Western Mediterranean. The city's Gothic Quarter bears witness to the splendor enjoyed by the city from the 13th to the 15th century.
The 20th century ushered in widespread urban renewal throughout Barcelona, culminating in its landmark Eixample district, which showcases some of the city's most distinctive Catalan art-nouveau, or modernista, buildings, including La Pedrera, Casa Batlló, and the Sagrada Família church, designed by Antoni Gaudí, one of the world's most eminent architects.
In 1992, Barcelona gained international recognition by hosting the Olympic games, which brought about a massive upturn in its tourism industry. For visitors, this has translated into the very modern yet incredibly old city you see now in the 21st century, where new elements work to both preserve and celebrate the city’s heritage and origins.
Barcelona has plenty of outdoor markets, restaurants, shops, museums, and churches. The city is also very walkable, with an extensive and reliable Metro system for more far-flung destinations.
Travel
Barcelona is a vibrant and accessible city with excellent transportation links. Whether you are arriving by plane, train, or other means, there are convenient options to reach your destination. Below, you will find detailed guidance to ensure a smooth journey to the conference venue.
By plane:
The international airport of Barcelona, Barcelona-El Prat, is located 10 km from the city center. It is well connected to major airport hubs in Europe and various locations worldwide. For more information about the airport and flights, please visit the official website: https://www.aena.es. Once you arrive at the airport, you have several options to reach the venue:
-
By train: Take the TRAIN R2 NORD (https://rodalies.gencat.cat). Disembark at Barcelona Sants station. From there, you can either take METRO L5 (get off at Diagonal) or a taxi, available just outside the station. The train from the airport costs EUR 4.60, and the metro costs EUR 2.65. Tickets can be purchased at train stations and metro stops, respectively. A taxi from the station to the conference venue costs approximately EUR 10.
-
By metro: Take LINE L9 (https://www.tmb.cat), which connects Barcelona Airport (both Terminal 1 and Terminal 2) to the city. Disembark at Collblanc station, and from there, transfer to METRO L5 (get off at Diagonal). The metro from the airport costs EUR 5.70, and the city metro costs EUR 2.65. Among the various ticket options offered by TBM is the Hola Barcelona Travel Card (from EUR 18.10, with a 10% online discount), covering unlimited public transport travel between the airport and the city centre at any time of day over a set time period (48, 72, 96, or 120 hours). For more information, please visit the official website: https://www.tmb.cat/en/barcelona-fares-metro-bus/tickets-visit-barcelona/barcelona-travel-card-hola-bcn.
-
By taxi: Taxis are readily available just outside the arrivals area. A taxi from the airport to the conference venue costs approximately EUR 30–35. Alternatively, VTC apps like Bolt and Cabify also operate in Barcelona and might offer more competitive rates.
By train:
Barcelona Sants is the city's largest train station, providing rail services for Barcelona, the rest of Spain, and international destinations. For more information about the station and train services, please visit the official website: https://www.renfe.com. Once you arrive at the station, you have the following options to reach the venue:
-
By metro: Take LINE L5 (https://www.tmb.cat) and get off at Diagonal.
-
By taxi: Taxis are available just outside the station. A taxi from the station to the conference venue costs approximately EUR 10.
Accommodation
We want your stay in Barcelona during the conference to be as comfortable as possible. With that in mind, we have agreed on a discount with several hotels to make your choice of accommodations easier. Please book your accommodation online and contact the hotels directly with any issues or requests related to accommodation bookings.
We are delighted to announce that the following hotels will offer a discounted price for all Antibiotics 2026 attendees:
Hotel |
Description |
How to book |
|
|
A 3-star boutique hotel located next to the emblematic Avenida Diagonal and Paseo de Gracia, the city's most chic shopping area and just 5 minutes on foot from the conference venue. The hotel has a terrace with an outdoor swimming pool and gym, parking, a restaurant, and a museum room dedicated to the Catalan illustrator Ricard Opisso. |
Click below to complete your booking and add the 5% discount code "AB2026", valid for stays between the 8th and 14th May 2026, booked through the official website starting September 2025.
|
|
|
A 4-star hotel located at the center of the Eixample district of Barcelona, the city's most exclusive shopping area, and only steps away from Barcelona's most famous monuments and tourist attractions. It is a great starting point to discover architectural jewels of Catalan modernism such as La Pedrera, Casa Batlló or the Sagrada Familia, and just 5 minutes on foot from the conference venue. The excellent range of services at the Balmes Hotel also includes its large, tree-covered interior garden with pool, gym, meeting rooms, bar and parking. |
Click below to complete your booking and add the 5% discount code "AB2026", valid for stays between the 8th and 14th May 2026, booked through the official website starting September 2025.
|
|
|
Stay in the heart of Barcelona's Eixample district at the Catalonia Diagonal Centro hotel, just a 1-minute walk from the conference venue. Located next to Passeig de Gràcia and close to the city's Modernist architecture route, the hotel offers excellent connections to various public transport options, making it easy to explore Barcelona for both tourism and business. |
Click below to make a reservation with a 10% discount for Catalonia Diagonal Centro or use the code "CATALONIABCN".
|
|
|
Discover the fascinating Barcelona, where the modern blends with the historical, and choose the 1881 Barcelona Gran Rosellón Hotel. It is just a 3-minute walk from the conference venue. |
Click below to complete your booking and add the 10% discount code "MDPI2026".
|
These accommodations have been carefully chosen to provide comfort and convenience for our guests while ensuring affordability through negotiated rates. Prepare to make the most of your conference experience with our exclusive lodging options designed to enhance your stay.
Beware of Unauthorized Registration and Hotel Solicitations
Note that Sciforum is the only official registration platform to register to Antibiotics 2026 and that we are not associated with any hotel agency (other than those listed above). While other hotel resellers and travel agencies may contact you with offers for your trip, they are not endorsed by or affiliated with Antibiotics 2026 or Sciforum. Beware that entering into financial agreements with non-endorsed companies can have costly consequences.
Visa Information
Please note that you must apply for your own visa application. MDPI is not responsible for any visa application. However, MDPI can provide a Visa Support Letter. To be eligible for such a document, the criteria below must be fulfilled.
Visa Support Letter
- Applicants must have paid for registration and submitted an abstract in order to get a letter of support.
- Applicants must provide us with a scan of their valid, in-date passport that contains a photo of them.
- Applicants must provide us with an academic CV, two references from their institution (contact information including institutional email and phone), and a letter of support from their institution to confirm that they support the delegate attending the meeting.
-
This must be carried out in good time before the meeting; “last minute” requests will not be processed.
More useful information on visa application
Partnership Opportunities
Sponsoring
As organizers, we are excited to create an immersive and insightful conference, and we invite you to be a vital part of Antibiotics 2026. Explore our sponsorship opportunities and join us in shaping the future of plant-related research and innovation.
Find the perfect sponsorship package tailored to your budget and desired exposure in our sponsorship brochure. Simply click on the icon below to access it.
If you have any questions, feel free to contact us via email at antibiotics2026@mdpi.com. We appreciate your consideration!
Society Collaboration
Are you part of a society that isn't partnering with the conference? Contact us via email at antibiotics2026@mdpi.com to discuss a possible partnership! Noteworthy detail: Members from partnering societies are granted a 20% discount on all registration fees.
Sponsors and Partners
Organizers
Media Partners
